Treatment
Medication clinical trials
We’re tracking 7,140 recruiting studies that include Medication, each written for real people, not researchers, below.
Recruiting studies
- NCT07010341Recruiting
Dye test to check parathyroid blood flow during thyroid surgery
This trial tests a dye called indocyanine green (ICG) to see how well it shows blood flow to the tiny parathyroid glands during thyroid surgery. This may help doctors know right away if the glands are healthy, which could lower the chance of complications.
Fuzhou, FujianAges Any age - NCT07003334Recruiting
Study on mental health and immune therapy for stomach cancer
This study looks at how psychological distress relates to immune checkpoint inhibitors in people with stomach cancer. It may help understand if emotional well-being affects treatment response.
Guangzhou, GuangdongAges 18–75 - NCT07012798RecruitingPhase 2
Sequential therapy for advanced liver cancer that may become removable
This trial tests a sequence of chemotherapy (FOLFOX), immunotherapy (durvalumab), targeted therapy (bevacizumab), and focused radiation to shrink liver tumors that are not removable now, with the goal of making them operable later.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT07008391Recruiting
High-sensitivity troponin test in ambulance care
This trial tests whether using a high-sensitivity troponin I test in the ambulance, along with standard care, can help emergency medical services better identify heart attacks. This might lead to faster treatment for patients with chest pain or suspected heart attack.
Stockholm, ÅrstaAges 18 years+ - NCT07003399Recruiting
Breathing Muscle Function in Sleep Apnea and COPD
This study looks at how the diaphragm (the main breathing muscle) and the drive to breathe work in people with sleep apnea, COPD, or both. Researchers want to compare these groups with healthy volunteers to better understand breathing problems.
Nanjing, JiangsuAges 18–80 - NCT07005505Recruiting
Comparing two breathing trial methods for ICU patients on ventilators
This study compares two ways to help patients breathe on their own during a spontaneous breathing trial (a test to see if they can come off the ventilator). It aims to find which method works better for adults in the ICU.
Chicago, IllinoisAges 18 years+ - NCT07012148RecruitingEarly Phase 1
Seizure forecasting device for temporal lobe epilepsy
This study tests a small device placed under the scalp that may help predict when seizures are likely to happen, using EEG (brain wave) readings. It is designed for people with temporal lobe epilepsy to improve seizure management and safety.
Scottsdale, ArizonaAges 18–75 - NCT07005141Recruiting
iHub Stent-Graft for Iliac Artery Aneurysms
This study tests a new stent-graft device for treating aneurysms in the iliac artery. It may be an option if you have an aneurysm that has grown or is large enough to need treatment.
Florianópolis, Santa CatarinaAges 18 years+ - NCT07007143RecruitingPhase 4
Blood thinner study after heart valve repair
This trial tests different blood-thinning medicines after a mitral valve repair procedure (TEER) in people who do not need long-term blood thinners. It aims to find the safest and most effective strategy to prevent blood clots.
Beijing, Beijing MunicipalityAges Any age - NCT07005453Recruiting
Studying a new way to measure polyp size during colonoscopy
This trial tests a tool that helps doctors more accurately measure the size of polyps found during colonoscopy. Accurate measurement helps decide the best next steps for your care.
Eindhoven, North BrabantAges 55–80 - NCT07006532Recruiting
Tocilizumab for chronic active antibody-mediated rejection
This trial tests whether the drug tocilizumab can help treat chronic active antibody-mediated rejection after a kidney transplant. It is for people whose kidney function is still fairly good and who have certain findings on biopsy.
TehranAges 18 years+ - NCT06998745Recruiting
Anticoagulant therapy support for colorectal cancer patients with blood clots
This trial tests whether a medication therapy management (MTM) model helps make blood thinner treatment safer and more effective for colorectal cancer patients who have also developed dangerous blood clots. It aims to improve how well patients stick to their medication and reduce complications.
Guangzhou, GuangdongAges 18–100 - NCT06999122Recruiting
Testing a new helmet-style brain scanner for stroke bleeding
This trial tests a new type of brain scanner (similar to a helmet) that looks for bleeding in the brain without radiation. It is for people who have had stroke-like symptoms in the last 24 hours and have not yet received treatment.
Los Angeles, CaliforniaAges 22 years+ - NCT07001332Recruiting
Circulatory support for high-risk angioplasty
This study tests a device that helps keep blood moving during a high-risk angioplasty (a procedure to open blocked heart arteries). It may help patients who are not good candidates for standard angioplasty alone.
Phoenix, ArizonaAges 18–88 - NCT07002034RecruitingPhase 2
RE104 for adjustment disorder related to cancer or other serious illnesses
This trial is testing a new medication (RE104) for people who have adjustment disorder with depressed mood or anxiety because of a serious medical condition like cancer, ALS, MS, Parkinson's, or lung fibrosis. It's a study to see if the drug is safe and reduces symptoms.
Birmingham, AlabamaAges 18–80 - NCT06997198RecruitingPhase 4
Deutetrabenazine for tardive dyskinesia in people with intellectual disabilities
This trial tests whether deutetrabenazine, a medication already used for tardive dyskinesia, can help people who also have intellectual or developmental disabilities. It aims to see if the drug reduces uncontrolled movements safely over 24 weeks.
Cleveland, OhioAges 18–89 - NCT07000916Recruiting
Follow-up study for new arthritis in kids and young adults
This study follows children and young adults newly diagnosed with certain types of arthritis or related conditions to learn more about their health over time. It may help doctors better understand how these diseases progress and how treatments work.
BrusselsAges 2–50 - NCT07002827Recruiting
Growth factors for early decompensated cirrhosis
This study tests whether a combination of two medicines (G-CSF and darbepoetin) given in one or more cycles can improve the body's immune and metabolic health in people with early-stage decompensated cirrhosis (advanced liver disease with mild complications). It compares these treatments with standard medical care.
New Delhi, National Capital Territory of DelhiAges 18–70 - NCT07000656Recruiting
Bladder training device for children with urinary problems
This trial tests a device that helps children with nighttime bedwetting, daytime urine leaks, or frequent urgent urination by teaching them to relax and control their bladder. It aims to improve symptoms without medication.
Shanghai, Shanghai MunicipalityAges 5–18 - NCT06994871Enrolling by invitation
Exercise and liver fat in fatty liver disease
This study tests if different types of exercise can reduce fat in the liver for people with metabolic fatty liver disease. It might help if you are looking for a non-drug way to improve your liver health.
Nanjing, JiangsuAges 18–45 - NCT06996756RecruitingPhase 1
Gene therapy for alpha-1 antitrypsin deficiency
This trial tests a gene therapy for people with alpha-1 antitrypsin deficiency who have mild to moderate lung disease. The aim is to see if the treatment can improve lung health and is safe.
New York, New YorkAges 18–70 - NCT07001943Recruiting
Blood flow in stomach and gut injury in ICU patients
This trial checks if changes in blood flow to the stomach and intestines can predict gut injury in critically ill patients who need feeding through a tube. It uses a safe ultrasound test at the bedside.
Beijing, Beijing MunicipalityAges 18–80 - NCT06998875RecruitingPhase 4
Study of avastin and tofacitinib for skin amyloidosis
This trial looks at people with primary cutaneous amyloidosis who have been treated with Avastin Capsules or Tofacitinib Citrate. It aims to track how well these medications work and if they are safe over time.
Chongqing, Chongqing MunicipalityAges 18 years+ - NCT06996119RecruitingPhase 1
Preventing graft-versus-host disease after stem cell transplant
This trial tests adding a drug called emapalumab to standard medications (cyclophosphamide, tacrolimus, mycophenolate mofetil) to prevent graft-versus-host disease in adults receiving a donor stem cell transplant. This approach aims to reduce complications after transplant.
Duarte, CaliforniaAges 18–75
Common questions
- Are there clinical trials studying Medication?
- Yes. Clin2 currently lists 7,140 recruiting studies that include Medication, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Medication trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Medication an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Medication or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.